/Parliament/Lord Moynihan of Chelsea

Lord Moynihan of Chelsea UK Shareholdings

LordsConservative

41 active interests, 2 ceased

Listed Company Interests (3)

Arbuthnot Banking GroupARBB

ShareholdingRegistered 5 Jan 2026

Oryx International Growth Fund LimitedOIG

ShareholdingRegistered 17 Mar 2025

Standard Chartered plcSTAN

ShareholdingRegistered 3 Oct 2025banking

Company	TIDM	Interest Type	Registered	Status	Nature of Business
Arbuthnot Banking Group	ARBB	Shareholding	5 Jan 2026	Active	–
Oryx International Growth Fund Limited	OIG	Shareholding	17 Mar 2025	Active	–
Standard Chartered plc	STAN	Shareholding	3 Oct 2025	Active	banking

Other Declared Interests (40)

ABB Ltd

ShareholdingRegistered 3 Oct 2025digital technologies

Asset Match

ShareholdingRegistered 18 Mar 2024private market trading platform

Avenue Therapeutics

ShareholdingRegistered 18 Mar 2024research and development in neurological diseases

Banco Santander

ShareholdingRegistered 3 Oct 2025

Brewdog

ShareholdingRegistered 18 Mar 2024brewing

Candel Therapeutics

ShareholdingRegistered 18 Mar 2024research and development in viral immunotherapies

CMT MTN PTE Ltd

ShareholdingRegistered 3 Oct 2025financial services

CQS Credit Multi Asset Fund

ShareholdingRegistered 18 Mar 2024research-driven credit strategies hedge fund

Cyngn Inc

ShareholdingRegistered 7 Feb 2025autonomous vehicle technology for industrial fleets

Deepbridge Life Sciences

ShareholdingRegistered 18 Mar 2024investment in healthcare innovation companies

East Rocky LLP

ShareholdingRegistered 18 Mar 2024hedge fund

FibaTech Industries

ShareholdingRegistered 18 Mar 2024production of fibre-reinforced polymers

Fortress Biotech

ShareholdingRegistered 18 Mar 2024research and development in biopharmaceuticals

Guinness Ventures

ShareholdingRegistered 18 Mar 2024investment in early-stage businesses

HzO

ShareholdingRegistered 18 Mar 2024nanocoating solutions for electronics

Itemize Corp

ShareholdingRegistered 18 Mar 2024financial transaction processing

Libero Pharma

ShareholdingRegistered 18 Mar 2024research and commercial development in opioid receptor antagonism

Linde plc

ShareholdingRegistered 3 Oct 2025chemicals and gas

Map of Agriculture

ShareholdingRegistered 18 Mar 2024global data platform connecting farms and industry

Money Hub

ShareholdingRegistered 18 Mar 2024financial services app

Mustang Bio

ShareholdingRegistered 18 Mar 2024research and development in next generation therapies

Optus Finance Pty

ShareholdingRegistered 3 Oct 2025

Plaquetec Limited

ShareholdingRegistered 18 Mar 2024research and commercial development concerning coronary heart disease

Ptarmigan Planning Ltd

ShareholdingRegistered 18 Mar 2024strategic land planning

Roche Kapitalmarkt

ShareholdingRegistered 3 Oct 2025

SAB Biotherapeutics

ShareholdingRegistered 7 Nov 2024biotechnology

Sabby Volatility Fund

ShareholdingRegistered 18 Mar 2024hedge fund

Singapore Life Holdings

ShareholdingRegistered 3 Oct 2025

Single Pass

ShareholdingRegistered 9 Jun 2025electrocautery device producer

Six Group AG

ShareholdingRegistered 3 Oct 2025financial market infrastructure

Sonorous NV

ShareholdingRegistered 18 Mar 2024research and commercial development in symptomatic cerebral venous diseases

Swiss Re Subordinated Finance

ShareholdingRegistered 3 Oct 2025

Terrestrial Energy

ShareholdingRegistered 18 Mar 2024molten salt and fission technology

Thermo Fisher Scientific Inc

ShareholdingRegistered 3 Oct 2025

Toronto Dominion Bank

ShareholdingRegistered 3 Oct 2025

Valorum Biologics

ShareholdingRegistered 15 May 2025pharmaceuticals

Vos Amis Limited

ShareholdingRegistered 18 Mar 2024investment advice, personal services and real estate

WebTel Mobi

ShareholdingRegistered 18 Mar 2024specialised network provider

AdaptimmuneCeased

ShareholdingRegistered 18 Mar 2024Ceased 14 Apr 2025cell therapy for cancer

TG TherapeuticsCeased

ShareholdingRegistered 18 Mar 2024Ceased 12 Nov 2025research and development in B-cell biologies

Company	Interest Type	Registered	Status	Nature of Business
ABB Ltd	Shareholding	3 Oct 2025	Active	digital technologies
Asset Match	Shareholding	18 Mar 2024	Active	private market trading platform
Avenue Therapeutics	Shareholding	18 Mar 2024	Active	research and development in neurological diseases
Banco Santander	Shareholding	3 Oct 2025	Active	–
Brewdog	Shareholding	18 Mar 2024	Active	brewing
Candel Therapeutics	Shareholding	18 Mar 2024	Active	research and development in viral immunotherapies
CMT MTN PTE Ltd	Shareholding	3 Oct 2025	Active	financial services
CQS Credit Multi Asset Fund	Shareholding	18 Mar 2024	Active	research-driven credit strategies hedge fund
Cyngn Inc	Shareholding	7 Feb 2025	Active	autonomous vehicle technology for industrial fleets
Deepbridge Life Sciences	Shareholding	18 Mar 2024	Active	investment in healthcare innovation companies
East Rocky LLP	Shareholding	18 Mar 2024	Active	hedge fund
FibaTech Industries	Shareholding	18 Mar 2024	Active	production of fibre-reinforced polymers
Fortress Biotech	Shareholding	18 Mar 2024	Active	research and development in biopharmaceuticals
Guinness Ventures	Shareholding	18 Mar 2024	Active	investment in early-stage businesses
HzO	Shareholding	18 Mar 2024	Active	nanocoating solutions for electronics
Itemize Corp	Shareholding	18 Mar 2024	Active	financial transaction processing
Libero Pharma	Shareholding	18 Mar 2024	Active	research and commercial development in opioid receptor antagonism
Linde plc	Shareholding	3 Oct 2025	Active	chemicals and gas
Map of Agriculture	Shareholding	18 Mar 2024	Active	global data platform connecting farms and industry
Money Hub	Shareholding	18 Mar 2024	Active	financial services app
Mustang Bio	Shareholding	18 Mar 2024	Active	research and development in next generation therapies
Optus Finance Pty	Shareholding	3 Oct 2025	Active	–
Plaquetec Limited	Shareholding	18 Mar 2024	Active	research and commercial development concerning coronary heart disease
Ptarmigan Planning Ltd	Shareholding	18 Mar 2024	Active	strategic land planning
Roche Kapitalmarkt	Shareholding	3 Oct 2025	Active	–
SAB Biotherapeutics	Shareholding	7 Nov 2024	Active	biotechnology
Sabby Volatility Fund	Shareholding	18 Mar 2024	Active	hedge fund
Singapore Life Holdings	Shareholding	3 Oct 2025	Active	–
Single Pass	Shareholding	9 Jun 2025	Active	electrocautery device producer
Six Group AG	Shareholding	3 Oct 2025	Active	financial market infrastructure
Sonorous NV	Shareholding	18 Mar 2024	Active	research and commercial development in symptomatic cerebral venous diseases
Swiss Re Subordinated Finance	Shareholding	3 Oct 2025	Active	–
Terrestrial Energy	Shareholding	18 Mar 2024	Active	molten salt and fission technology
Thermo Fisher Scientific Inc	Shareholding	3 Oct 2025	Active	–
Toronto Dominion Bank	Shareholding	3 Oct 2025	Active	–
Valorum Biologics	Shareholding	15 May 2025	Active	pharmaceuticals
Vos Amis Limited	Shareholding	18 Mar 2024	Active	investment advice, personal services and real estate
WebTel Mobi	Shareholding	18 Mar 2024	Active	specialised network provider
Adaptimmune	Shareholding	18 Mar 2024	Ceased 14 Apr 2025	cell therapy for cancer
TG Therapeutics	Shareholding	18 Mar 2024	Ceased 12 Nov 2025	research and development in B-cell biologies

Listed Company Interests (3)

Arbuthnot Banking GroupARBB

ShareholdingRegistered 5 Jan 2026

Oryx International Growth Fund LimitedOIG

ShareholdingRegistered 17 Mar 2025

Standard Chartered plcSTAN

ShareholdingRegistered 3 Oct 2025banking

Company	TIDM	Interest Type	Registered	Status	Nature of Business
Arbuthnot Banking Group	ARBB	Shareholding	5 Jan 2026	Active	–
Oryx International Growth Fund Limited	OIG	Shareholding	17 Mar 2025	Active	–
Standard Chartered plc	STAN	Shareholding	3 Oct 2025	Active	banking

Other Declared Interests (40)

ABB Ltd

ShareholdingRegistered 3 Oct 2025digital technologies

Asset Match

ShareholdingRegistered 18 Mar 2024private market trading platform

Avenue Therapeutics

ShareholdingRegistered 18 Mar 2024research and development in neurological diseases

Banco Santander

ShareholdingRegistered 3 Oct 2025

Brewdog

ShareholdingRegistered 18 Mar 2024brewing

Candel Therapeutics

ShareholdingRegistered 18 Mar 2024research and development in viral immunotherapies

CMT MTN PTE Ltd

ShareholdingRegistered 3 Oct 2025financial services

CQS Credit Multi Asset Fund

ShareholdingRegistered 18 Mar 2024research-driven credit strategies hedge fund

Cyngn Inc

ShareholdingRegistered 7 Feb 2025autonomous vehicle technology for industrial fleets

Deepbridge Life Sciences

ShareholdingRegistered 18 Mar 2024investment in healthcare innovation companies

East Rocky LLP

ShareholdingRegistered 18 Mar 2024hedge fund

FibaTech Industries

ShareholdingRegistered 18 Mar 2024production of fibre-reinforced polymers

Fortress Biotech

ShareholdingRegistered 18 Mar 2024research and development in biopharmaceuticals

Guinness Ventures

ShareholdingRegistered 18 Mar 2024investment in early-stage businesses

HzO

ShareholdingRegistered 18 Mar 2024nanocoating solutions for electronics

Itemize Corp

ShareholdingRegistered 18 Mar 2024financial transaction processing

Libero Pharma

ShareholdingRegistered 18 Mar 2024research and commercial development in opioid receptor antagonism

Linde plc

ShareholdingRegistered 3 Oct 2025chemicals and gas

Map of Agriculture

ShareholdingRegistered 18 Mar 2024global data platform connecting farms and industry

Money Hub

ShareholdingRegistered 18 Mar 2024financial services app

Mustang Bio

ShareholdingRegistered 18 Mar 2024research and development in next generation therapies

Optus Finance Pty

ShareholdingRegistered 3 Oct 2025

Plaquetec Limited

ShareholdingRegistered 18 Mar 2024research and commercial development concerning coronary heart disease

Ptarmigan Planning Ltd

ShareholdingRegistered 18 Mar 2024strategic land planning

Roche Kapitalmarkt

ShareholdingRegistered 3 Oct 2025

SAB Biotherapeutics

ShareholdingRegistered 7 Nov 2024biotechnology

Sabby Volatility Fund

ShareholdingRegistered 18 Mar 2024hedge fund

Singapore Life Holdings

ShareholdingRegistered 3 Oct 2025

Single Pass

ShareholdingRegistered 9 Jun 2025electrocautery device producer

Six Group AG

ShareholdingRegistered 3 Oct 2025financial market infrastructure

Sonorous NV

ShareholdingRegistered 18 Mar 2024research and commercial development in symptomatic cerebral venous diseases

Swiss Re Subordinated Finance

ShareholdingRegistered 3 Oct 2025

Terrestrial Energy

ShareholdingRegistered 18 Mar 2024molten salt and fission technology

Thermo Fisher Scientific Inc

ShareholdingRegistered 3 Oct 2025

Toronto Dominion Bank

ShareholdingRegistered 3 Oct 2025

Valorum Biologics

ShareholdingRegistered 15 May 2025pharmaceuticals

Vos Amis Limited

ShareholdingRegistered 18 Mar 2024investment advice, personal services and real estate

WebTel Mobi

ShareholdingRegistered 18 Mar 2024specialised network provider

AdaptimmuneCeased

ShareholdingRegistered 18 Mar 2024Ceased 14 Apr 2025cell therapy for cancer

TG TherapeuticsCeased

ShareholdingRegistered 18 Mar 2024Ceased 12 Nov 2025research and development in B-cell biologies

Company	Interest Type	Registered	Status	Nature of Business
ABB Ltd	Shareholding	3 Oct 2025	Active	digital technologies
Asset Match	Shareholding	18 Mar 2024	Active	private market trading platform
Avenue Therapeutics	Shareholding	18 Mar 2024	Active	research and development in neurological diseases
Banco Santander	Shareholding	3 Oct 2025	Active	–
Brewdog	Shareholding	18 Mar 2024	Active	brewing
Candel Therapeutics	Shareholding	18 Mar 2024	Active	research and development in viral immunotherapies
CMT MTN PTE Ltd	Shareholding	3 Oct 2025	Active	financial services
CQS Credit Multi Asset Fund	Shareholding	18 Mar 2024	Active	research-driven credit strategies hedge fund
Cyngn Inc	Shareholding	7 Feb 2025	Active	autonomous vehicle technology for industrial fleets
Deepbridge Life Sciences	Shareholding	18 Mar 2024	Active	investment in healthcare innovation companies
East Rocky LLP	Shareholding	18 Mar 2024	Active	hedge fund
FibaTech Industries	Shareholding	18 Mar 2024	Active	production of fibre-reinforced polymers
Fortress Biotech	Shareholding	18 Mar 2024	Active	research and development in biopharmaceuticals
Guinness Ventures	Shareholding	18 Mar 2024	Active	investment in early-stage businesses
HzO	Shareholding	18 Mar 2024	Active	nanocoating solutions for electronics
Itemize Corp	Shareholding	18 Mar 2024	Active	financial transaction processing
Libero Pharma	Shareholding	18 Mar 2024	Active	research and commercial development in opioid receptor antagonism
Linde plc	Shareholding	3 Oct 2025	Active	chemicals and gas
Map of Agriculture	Shareholding	18 Mar 2024	Active	global data platform connecting farms and industry
Money Hub	Shareholding	18 Mar 2024	Active	financial services app
Mustang Bio	Shareholding	18 Mar 2024	Active	research and development in next generation therapies
Optus Finance Pty	Shareholding	3 Oct 2025	Active	–
Plaquetec Limited	Shareholding	18 Mar 2024	Active	research and commercial development concerning coronary heart disease
Ptarmigan Planning Ltd	Shareholding	18 Mar 2024	Active	strategic land planning
Roche Kapitalmarkt	Shareholding	3 Oct 2025	Active	–
SAB Biotherapeutics	Shareholding	7 Nov 2024	Active	biotechnology
Sabby Volatility Fund	Shareholding	18 Mar 2024	Active	hedge fund
Singapore Life Holdings	Shareholding	3 Oct 2025	Active	–
Single Pass	Shareholding	9 Jun 2025	Active	electrocautery device producer
Six Group AG	Shareholding	3 Oct 2025	Active	financial market infrastructure
Sonorous NV	Shareholding	18 Mar 2024	Active	research and commercial development in symptomatic cerebral venous diseases
Swiss Re Subordinated Finance	Shareholding	3 Oct 2025	Active	–
Terrestrial Energy	Shareholding	18 Mar 2024	Active	molten salt and fission technology
Thermo Fisher Scientific Inc	Shareholding	3 Oct 2025	Active	–
Toronto Dominion Bank	Shareholding	3 Oct 2025	Active	–
Valorum Biologics	Shareholding	15 May 2025	Active	pharmaceuticals
Vos Amis Limited	Shareholding	18 Mar 2024	Active	investment advice, personal services and real estate
WebTel Mobi	Shareholding	18 Mar 2024	Active	specialised network provider
Adaptimmune	Shareholding	18 Mar 2024	Ceased 14 Apr 2025	cell therapy for cancer
TG Therapeutics	Shareholding	18 Mar 2024	Ceased 12 Nov 2025	research and development in B-cell biologies